Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NXDT | 5.50% Series A Cumulative Preferred Shares | Purchase | $142K | +8.93K | $15.93 | 8.93K | Mar 7, 2023 | See Footnote | F1 | |
transaction | NXDT | 5.50% Series A Cumulative Preferred Shares | Purchase | $77.6K | +4.9K | +54.87% | $15.83 | 13.8K | Mar 8, 2023 | See Footnote | F1 |
holding | NXDT | 5.50% Series A Cumulative Preferred Shares | 13K | Mar 7, 2023 | See Footnote | F2 | |||||
holding | NXDT | 5.50% Series A Cumulative Preferred Shares | 46K | Mar 7, 2023 | See Footnote | F3 |
Id | Content |
---|---|
F1 | These shares are held by Highland Global Allocation Fund, which is managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management") (f/k/a Highland Capital Management Fund Advisers, L.P.). Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of shares held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F2 | These shares are held by Drugcrafters, L.P. ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F3 | These shares are held by a trust of which Mr. Dondero is the beneficiary pursuant to an employee purchase plan. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
President